Stable angina pectoris

Indication for Ranolazine

Population group: Suitable for both men and women, only adults (18 years old or older)

Ranolazine is indicated in adults as add-on therapy for the symptomatic treatment of patients with stable angina pectoris who are inadequately controlled or intolerant to first-line antianginal therapies (such as beta-blockers and/or calcium antagonists).

For this indication, competent medicine agencies globally authorize below treatments:

750-1500 mg in 2 divided doses daily

Route of admnistration


Defined daily dose

750 - 1,500 mg

Dosage regimen

From 375 To 750 mg 2 time(s) per day every day

Detailed description

The recommended initial dose of ranolazine is 375 mg twice daily. After 2–4 weeks, the dose should be titrated to 500 mg twice daily and, according to the patient’s response, further titrated to a recommended maximum dose of 750 mg twice daily.

If a patient experiences treatment-related adverse events (e.g. dizziness, nausea, or vomiting), downtitration of ranolazine to 500 mg or 375 mg twice daily may be required. If symptoms do not resolve after dose reduction, treatment should be discontinued.

The incidence of adverse events was higher in patients with low weight (≤60 kg). Dose titration in patients with low weight should be exercised with caution.


Dose titration in elderly patients should be exercised with caution. Elderly may have increased ranolazine exposure due to age-related decrease in renal function. The incidence of adverse events was higher in the elderly.

Dosage considerations

They may be taken with or without food.

Active ingredient

Ranolazine may have some antianginal effects by inhibition of the late sodium current in cardiac cells. This reduces intracellular sodium accumulation and consequently decreases intracellular calcium overload. Ranolazine, via its action to decrease the late sodium current, is considered to reduce these intracellular ionic imbalances during ischaemia. This reduction in cellular calcium overload is expected to improve myocardial relaxation and thereby decrease left ventricular diastolic stiffness.

Read more about Ranolazine

Related medicines

Develop a tailored medication plan for your case, considering factors such as age, gender, and health history

Ask the Reasoner